glp-1 hfpef Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document - Monzo - 2025 Effects of Glucagon-Like Peptide 1

This allows us to create personalized plans that combine evidence-based therapieslike hormone optimization, IV infusions, or ketamine therapywith natural supports, fostering long-term wellness rather than temporary fixes

Every expired injection introduces an unknown variable that undermines the precision your protocol requires

Without an accompanying dietary and behavioural change support, patients can experience nutritional deficiencies, a loss of lean muscle mass and will not be equipped to cope after the course of medication ends

The drugs are also intended to be prescribed along with other lifestyle changes, like a healthy diet and exercise

Jin-Zhou Zheng, [email protected]